Articles about EnzySystem HemA acceptance

In August 2024, EnzySystem for Haemophilia A was evaluated on acceptability and usability by health care professionals (HCPs) and persons with haemophilia A and caregivers (PwHA/C) in Hemophilia Treatment Center in Indianapolis (Indiana, USA). The results of these studies show high acceptance and usefulness in various scenarios by both HCPS and PwHA/C groups. We are happy to share the questionnaire results in recently published articles in peer reviewed journals!

1. Acceptability and Determinants for Implementation of the EnzySystem, a Novel Near-Patient Testing Platform for Haemophilia A https://doi.org/10.1111/hae.70191
2. Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation https://doi.org/10.2196/77621